Critical need for clinical trials: An example of a pilot human intervention trial of a mixture of natural agents protecting lymphocytes against TNF-α induced activation of NF-κB

Pharmaceutical Research

Volumn 27, Issue 6, 2010, Pages 1061-1065

  Dominiak, Kristin ^a   McKinney, Jaclyn ^a   Heilbrun, Lance K ^a   Sarkar, Fazlul H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Curcumin; Epigallocatechin 3 gallate (EGCG); Isoflavone; NF B; Resveratrol; TNF

Indexed keywords

CURCUMIN; EPIGALLOCATECHIN GALLATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOFLAVONE; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIOXIDANT ACTIVITY; BLOOD SAMPLING; CELL PROTECTION; CLINICAL STUDY; DNA BINDING; DRUG CAPSULE; EX VIVO STUDY; HUMAN; IN VIVO STUDY; INTERVENTION STUDY; LYMPHOCYTE; NOTE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

ADULT; BIOLOGICAL PRODUCTS; CATECHIN; CURCUMIN; DNA; FEMALE; HUMANS; ISOFLAVONES; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; NF-KAPPA B; OXIDATIVE STRESS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77953228966     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0113-y     Document Type: Note

References (9)

1. FH Sarkar Y Li 2008 NF-kappaB: a potential target for cancer chemoprevention and therapy Front Biosci. 13 2950 9 10.2741/2900 1:CAS:528:DC%2BD1cXhs1CnsbY%3D 17981768 (Pubitemid 351589211)
2. YJ Surh 2003 Cancer chemoprevention with dietary phytochemicals Nat Rev Cancer 3 768 80 10.1038/nrc1189 1:CAS:528:DC%2BD3sXotFChsLw%3D 14570043
3. JN Davis O Kucuk Z Djuric FH Sarkar 2001 Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes Free Radic Biol Med. 30 1293 302 10.1016/S0891-5849(01)00535-4 1:CAS:528:DC%2BD3MXjsFegtbw%3D 11368927 (Pubitemid 32463940)
4. S Banerjee Y Zhang Z Wang M Che PJ Chiao JL Abbruzzese, et al. 2007 In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer Int J Cancer 120 906 17 10.1002/ijc.22332 1:CAS:528:DC%2BD2sXht1elt7k%3D 17131310 (Pubitemid 46175414)
5. Y Li F Ahmed S Ali PA Philip O Kucuk FH Sarkar 2005 Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells Cancer Res. 65 6934 42 10.1158/0008-5472.CAN-04-4604 1:CAS:528:DC%2BD2MXmvFSlurg%3D 16061678 (Pubitemid 41060733)
6. BF El-Rayes S Ali IF Ali PA Philip J Abbruzzese FH Sarkar 2006 Potentiation of the effect of erlotinib by genistein in pancreatic cancer: the role of Akt and nuclear factor-kappaB Cancer Res. 66 10553 9 10.1158/0008-5472.CAN-06-2333 1:CAS:528:DC%2BD28XhtFGjsrfO 17079479 (Pubitemid 44799778)
7. Z Wang S Desmoulin S Banerjee D Kong Y Li RL Deraniyagala, et al. 2008 Synergistic effects of multiple natural products in pancreatic cancer cells Life Sci. 83 293 300 10.1016/j.lfs.2008.06.017 1:CAS:528:DC%2BD1cXps1Ghu7o%3D 18640131
8. N Khansari Y Shakiba M Mahmoudi 2009 Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer Recent Pat Inflamm Allergy Drug Discov. 3 73 80 10.2174/187221309787158371 1:CAS:528: DC%2BD1MXks1ChsL0%3D 19149749
9. FH Sarkar Y Li Z Wang D Kong 2008 NF-kappaB signaling pathway and its therapeutic implications in human diseases Int Rev Immunol. 27 293 319 10.1080/08830180802276179 1:CAS:528:DC%2BD1cXht1eksbfF 18853341